{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:11:52Z","timestamp":1782951112649,"version":"3.54.5"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["111-2314-B-038-139"],"award-info":[{"award-number":["111-2314-B-038-139"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["NSTC113-2314-B038-125"],"award-info":[{"award-number":["NSTC113-2314-B038-125"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004700","name":"Taipei Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.biopha.2025.117968","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T22:58:25Z","timestamp":1742684305000},"page":"117968","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["S-hydroxychloroquine prevents the antiphospholipid thrombogenic complexes for antiphospholipid syndrome treatment"],"prefix":"10.1016","volume":"186","author":[{"given":"Ming-Shou","family":"Hsieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng-Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-You","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deng-Pan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsu-Yi","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iat-Hang","family":"Fong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Sheng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5189-9755","authenticated-orcid":false,"given":"Chi-Tai","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.117968_bib1","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2023184","article-title":"Repurposed antiviral drugs for covid-19 - interim who solidarity trial results","volume":"384","author":"Pan","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2025.117968_bib2","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2009-04-213520","article-title":"Hydroxychloroquine protects the annexin a5 anticoagulant shield from disruption by antiphospholipid antibodies: Evidence for a novel effect for an old antimalarial drug","volume":"115","author":"Rand","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2025.117968_bib3","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.blre.2017.07.006","article-title":"Diagnosis and management of the antiphospholipid syndrome","volume":"31","author":"Chaturvedi","year":"2017","journal-title":"Blood Rev."},{"key":"10.1016\/j.biopha.2025.117968_bib4","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.clim.2004.02.009","article-title":"The effect of phospholipids on the formation of immune complexes between autoantibodies and \u03b22-glycoprotein i or prothrombin","volume":"112","author":"Bevers","year":"2004","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.biopha.2025.117968_bib5","doi-asserted-by":"crossref","first-page":"15542","DOI":"10.1073\/pnas.95.26.15542","article-title":"Anti-beta2 glycoprotein i (beta2gpi) autoantibodies recognize an epitope on the first domain of beta2gpi","volume":"95","author":"Iverson","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2025.117968_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.726820","article-title":"Antiphospholipid antibody assays in 2021: Looking for a predictive value in addition to a diagnostic one","volume":"12","author":"Meroni","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2025.117968_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/antib5020012","article-title":"\u03922gp1, anti-\u03b22gp1 antibodies and platelets: Key players in the antiphospholipid syndrome","volume":"5","author":"Ho","year":"2016","journal-title":"Antibodies"},{"key":"10.1016\/j.biopha.2025.117968_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9020132","article-title":"Immunosuppressive treatment in antiphospholipid syndrome: Is it worth it?","volume":"9","author":"Mormile","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2025.117968_bib9","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/0961203310361485","article-title":"The annexin a5-mediated pathogenic mechanism in the antiphospholipid syndrome: Role in pregnancy losses and thrombosis","volume":"19","author":"Rand","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.biopha.2025.117968_bib10","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.15760","article-title":"Dissimilar effects of stereoisomers and racemic hydroxychloroquine on ca(2+) oscillations in human induced pluripotent stem cell-derived cardiomyocytes","volume":"11","author":"Janicki","year":"2023","journal-title":"Physiol. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2025.117968_bib11","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1177\/0961203396005001041","article-title":"Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseases","volume":"5","author":"Furst","year":"1996","journal-title":"Lupus"},{"key":"10.1016\/j.biopha.2025.117968_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.715878","article-title":"Use of direct oral anticoagulants in patients with antiphospholipid syndrome: A systematic review and comparison of the international guidelines","volume":"8","author":"Pastori","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.biopha.2025.117968_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021331","article-title":"Hydroxychloroquine as an immunomodulatory and antithrombotic treatment in antiphospholipid syndrome","volume":"24","author":"Arachchillage","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.117968_bib14","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.autrev.2014.12.006","article-title":"Hydroxychloroquine as an anti-thrombotic in antiphospholipid syndrome","volume":"14","author":"Belizna","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.biopha.2025.117968_bib15","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.autrev.2018.05.012","article-title":"Hibiscus: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome","volume":"17","author":"Belizna","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.biopha.2025.117968_bib16","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1046\/j.1365-2249.2003.02180.x","article-title":"Beta-2-glycoprotein i expression on monocytes is increased in anti-phospholipid antibody syndrome and correlates with tissue factor expression","volume":"132","author":"Conti","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.biopha.2025.117968_bib17","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.mex.2019.04.023","article-title":"Methodology of generation and purification of anti-beta 2 glycoprotein i antibodies","volume":"6","author":"Alarcon","year":"2019","journal-title":"MethodsX"},{"key":"10.1016\/j.biopha.2025.117968_bib18","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1055\/s-0038-1642501","article-title":"Effect of human igg antiphospholipid antibodies on an in vivo thrombosis model in mice","volume":"71","author":"Pierangeli","year":"1994","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.biopha.2025.117968_bib19","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.jtha.2024.02.011","article-title":"2023 isth update of the 2022 isth guidelines for antithrombotic treatment in covid-19","volume":"22","author":"Schulman","year":"2024","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.biopha.2025.117968_bib20","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X211073001","article-title":"Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge","volume":"14","author":"Dima","year":"2022","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"10.1016\/j.biopha.2025.117968_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15133477","article-title":"The coagulopathy of acute promyelocytic leukemia: An updated review of pathophysiology, risk stratification, and clinical management","volume":"15","author":"Hermsen","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.biopha.2025.117968_bib22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fncel.2019.00107","article-title":"Antiphospholipid antibodies overlapping in isolated neurological syndrome and multiple sclerosis: neurobiological insights and diagnostic challenges","volume":"13","author":"D'Angelo","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.biopha.2025.117968_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21217975","article-title":"Factors affecting the formation and treatment of thrombosis by natural and synthetic compounds","volume":"21","author":"Lichota","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.117968_bib24","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1182\/blood-2018-11-882993","article-title":"Thromboinflammation: Challenges of therapeutically targeting coagulation and other host defense mechanisms","volume":"133","author":"Jackson","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2025.117968_bib25","article-title":"The pathophysiology of the antiphospholipid syndrome: A perspective from the blood coagulation system. Clinical and applied thrombosis\/hemostasis","volume":"28","author":"Arreola-Diaz","year":"2022","journal-title":"Off. J. Int. Acad. Clin. Appl. Thromb. \/Hemost."},{"key":"10.1016\/j.biopha.2025.117968_bib26","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jtha.2022.12.002","article-title":"Targeting thromboinflammation in antiphospholipid syndrome","volume":"21","author":"Salet","year":"2023","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.biopha.2025.117968_bib27","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1182\/blood-2008-03-144204","article-title":"Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein i complexes to phospholipid bilayers","volume":"112","author":"Rand","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2025.117968_bib28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3899\/jrheum.120157","article-title":"Hydroxychloroquine use is associated with lower odds of persistently positive antiphospholipid antibodies and\/or lupus anticoagulant in systemic lupus erythematosus","volume":"40","author":"Broder","year":"2013","journal-title":"J. Rheuma"},{"key":"10.1016\/j.biopha.2025.117968_bib29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.5152\/eurjrheum.2015.0085","article-title":"The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus","volume":"3","author":"\u00dcnl\u00fc","year":"2016","journal-title":"Eur. J. Rheumatol."},{"key":"10.1016\/j.biopha.2025.117968_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206814","article-title":"Hydroxychloroquine partially prevents endothelial dysfunction induced by anti-beta-2-gpi antibodies in an in vivo mouse model of antiphospholipid syndrome","volume":"13","author":"Urbanski","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.biopha.2025.117968_bib31","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1055\/s-0036-1597286","article-title":"New insights in the pathophysiology of antiphospholipid syndrome","volume":"44","author":"Sacharidou","year":"2018","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.biopha.2025.117968_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12030891","article-title":"Advances in the pathophysiology of thrombosis in antiphospholipid syndrome: molecular mechanisms and signaling through lipid rafts","volume":"12","author":"Capozzi","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.biopha.2025.117968_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11123135","article-title":"Role of lipid rafts on lrp8 signaling triggered by anti-\u03b22-gpi antibodies in endothelial cells","volume":"11","author":"Riitano","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2025.117968_bib34","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fimmu.2019.00085","article-title":"Cell type-specific roles of nf-\u03bab linking inflammation and thrombosis","volume":"10","author":"Mussbacher","year":"2019","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2025.117968_bib35","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1083\/jcb.147.2.447","article-title":"Aggregation of lipid rafts accompanies signaling via the t cell antigen receptor","volume":"147","author":"Janes","year":"1999","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.biopha.2025.117968_bib36","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1182\/blood.2019001530","article-title":"Tissue factor pathway inhibitor primes monocytes for antiphospholipid antibody-induced thrombosis","volume":"134","author":"M\u00fcller-Calleja","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2025.117968_bib37","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1186\/s12964-024-01876-4","article-title":"Lipid rafts, caveolae, and epidermal growth factor receptor family: Friends or foes?","volume":"22","author":"Ruzzi","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.biopha.2025.117968_bib38","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1158\/0008-5472.CAN-20-2199","article-title":"Rafting down the metastatic cascade: the role of lipid rafts in cancer metastasis, cell death, and clinical outcomes","volume":"81","author":"Greenlee","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2025.117968_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1361519","article-title":"Interaction of antiphospholipid antibodies with endothelial cells in antiphospholipid syndrome","volume":"15","author":"Feng","year":"2024","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2025.117968_bib40","doi-asserted-by":"crossref","unstructured":"Yuan, Z.; Pavel, M.A.; Wang, H.; Hansen, S.B. Hydroxychloroquine: Mechanism of action inhibiting sars-cov2 entry. bioRxiv: the preprint server for biology 2020.","DOI":"10.1101\/2020.08.13.250217"},{"key":"10.1016\/j.biopha.2025.117968_bib41","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/jth.15558","article-title":"Effect of heparanase inhibitor on tissue factor overexpression in platelets and endothelial cells induced by anti-\u03b22-gpi antibodies: reply to comment from mackman et al","volume":"20","author":"Capozzi","year":"2022","journal-title":"J. Thromb. Haemost.: JTH"},{"key":"10.1016\/j.biopha.2025.117968_bib42","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1016\/j.biomaterials.2006.01.012","article-title":"Characterizing the modification of surface proteins with poly(ethylene glycol) to interrupt platelet adhesion","volume":"27","author":"Xu","year":"2006","journal-title":"Biomaterials"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225001623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225001623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T23:01:42Z","timestamp":1781823702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225001623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":42,"alternative-id":["S0753332225001623"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.117968","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"S-hydroxychloroquine prevents the antiphospholipid thrombogenic complexes for antiphospholipid syndrome treatment","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.117968","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117968"}}